Chen L et al. reported that the miR-200/ZEB1 axis could regulate the EMT signature on tumour cells and simultaneously target the PD-L1, leading to CD8+ T cell immunosuppression and metastasis [38]. This evidence concerns the gene ZEB1 and neoplasm.